Glenmark Associates, Inc. v. Americare of West Virginia, Inc.

371 S.E.2d 353, 179 W. Va. 632, 1988 W. Va. LEXIS 106
CourtWest Virginia Supreme Court
DecidedJuly 18, 1988
Docket17555
StatusPublished
Cited by16 cases

This text of 371 S.E.2d 353 (Glenmark Associates, Inc. v. Americare of West Virginia, Inc.) is published on Counsel Stack Legal Research, covering West Virginia Supreme Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Glenmark Associates, Inc. v. Americare of West Virginia, Inc., 371 S.E.2d 353, 179 W. Va. 632, 1988 W. Va. LEXIS 106 (W. Va. 1988).

Opinion

PER CURIAM:

This is an appeal from a final order of the Circuit Court of Monongalia County, entered February 23, 1986, which granted summary judgment in favor of the appel-lees, Americare of West Virginia, Inc. and Morgantown Health Care Corp., in a civil action brought by the appellant, Glenmark Associates, Inc., to enforce an agreement for the sale of stock. The circuit court concluded that the appellant had failed to perform in a timely manner certain conditions precedent to the vesting of its rights under the agreement. We conclude that the court erred in not considering extrinsic evidence as to the time and manner of performance, and we reverse the judgment of the circuit court.

Glenmark Associates, Inc. (hereinafter, “Glenmark”) is a health care development and management firm whose principal office is located in Morgantown, Monongalia County. Americare of West Virginia, Inc. (hereinafter, “Americare”) owns all of the *634 issued and outstanding shares of capital stock of Morgantown Health Care Corp., which, in turn, owns a skilled and intermediate care nursing facility in Morgantown. Americare is a wholly-owned subsidiary of Americare Corp., an Ohio corporation.

In the fall of 1984, Americare entered into negotiations to sell its Morgantown Health Care Corp. stock to Glenmark. The principal negotiators in this transaction were Mark Nesselroad, president of Glen-mark, and Chester Howard Bradeen, senior vice-president of Americare Corp.

On January 8, 1985, Mr. Bradeen met with Mr. Nesselroad in Morgantown, and the two men executed a stock purchase agreement prepared by David M. Kauff-man, corporate counsel and executive vice-president of Americare Corp. Under the terms of the agreement, Glenmark was allowed thirty days in which to consummate the transaction. Paragraph 4(b) of the agreement provided:

The time period for consummation hereunder may be extended for an additional thirty (30) day period by the Buyer paying to the Seller an additional sum of FIVE THOUSAND AND NO/100 DOLLARS ($5,000.00) and providing to Seller a copy of an executed Preliminary Commitment, or other evidence reasonably acceptable to Seller showing the availability of financing subject only to the usual and customary conditions contained in commitments of this type. This sum is to be credited toward the purchase price at closing.

Paragraph 4(c) of the agreement allowed for an additional forty-five day extension of the time upon the payment by Glenmark of an additional $50,000 to an escrow agent.

Mr. Bradeen and Mr. Nesselroad were scheduled to meet with Mr. Kauffman on February 1, 1985 to discuss provisions of the agreement relating to control of the assets of Morgantown Health Care Corp. and bond restrictions. When Mr. Nessel-road was unable to attend due to inclement weather, the meeting was rescheduled for February 11, 1985, several days after the expiration of the initial thirty-day term of the agreement.

On February 8, 1985, Mr. Nesselroad telephoned Mr. Bradeen to discuss obtaining the thirty-day extension provided under Paragraph 4(b) of the agreement. Mr. Nesselroad offered to mail a $5,000 check to Americare that day in satisfaction of the conditions of Paragraph 4(b), but was advised that he could simply bring the check to the meeting scheduled for the following Monday. The parties also discussed allowing Glenmark to provide the evidence of availability of financing contemplated by Paragraph 4(b) at the February 11 meeting.

On February 10, 1985, Mr. Bradeen telephoned Mr. Nesselroad to cancel the meeting scheduled for the following day. At that time, Mr. Nesselroad requested, and Mr. Bradeen agreed to consider providing, a letter of extension stating that Americare would allow Glenmark to satisfy the terms of Paragraph 4(b) at a future meeting to be scheduled by the parties.

Sometime thereafter, Mr. Nesselroad learned that Americare Corp. was being sold to another corporation. 1 On February 12, 1985, Glenmark mailed a $5,000 check to Mr. Bradeen. The following day, Glen-mark forwarded to Mr. Bradeen a letter from C. Barton Loar, senior vice-president of the First National Bank of Morgantown, dated February 13, 1985. Mr. Loar’s letter stated that the bank had reviewed and was looking favorably upon Glenmark’s financing proposal but wished to review the loan application further. Mr. Loar further stated that the bank was “working toward giving you an approval at the earliest possible date.” Letters from Mr. Nesselroad accompanying both the check and Mr. Loar’s letter indicated that these documents were to have been delivered at the February 11 meeting in satisfaction of the conditions of Paragraph 4(b) and requested that the cancelled meeting be rescheduled.

By letter dated February 18, 1985, Mr. Kauffman advised Mr. Nesselroad that the *635 letter from Mr. Loar did not satisfy the “Preliminary Commitment” requirement of Paragraph 4(b). Mr. Kauffman further advised Mr. Nesselroad that as a result of Glenmark’s failure to provide adequate evidence of the availability of financing, Am-ericare considered the agreement terminated.

On March 7,1985, Glenmark deposited in an escrow account the $50,000 required to obtain the forty-five day extension under Paragraph 4(c). By letter dated that same day, Mr. Loar informed Glenmark that its application for a loan had been approved.

On March 12, 1985, Glenmark instituted a declaratory judgment action in the Circuit Court of Monongalia County seeking a declaration of its right to purchase the stock of Morgantown Health Care Corp. under the stock purchase agreement. 2 After the expiration of the forty-five day extension period, Glenmark amended its complaint seeking specific performance of the agreement, or in the alternative, compensatory damages of at least $100,000.

In pre-trial depositions, Mr. Bradeen, Mr. Kauffman and Mr. Nesselroad testified as to their understanding of the terms of Paragraph 4(b) and to Glenmark’s attempts at compliance. On January 23, 1986, the appellees filed a motion in limine to exclude all evidence offered by Glenmark to explain, modify or contradict the terms of the stock purchase agreement on the ground that such evidence violated the parol evidence rule and was not admissible at trial. The same day, the appellees filed a motion for summary judgment.

By memorandum order entered February 27, 1986, the circuit court ruled that the language of Paragraph 4(b), when read in conjunction with the entire agreement, clearly contemplated that written evidence of the availability of financing was to be provided by Glenmark prior to the end of the initial thirty-day term as a condition precedent to the granting of an extension and that parol evidence was not admissible to vary or contradict this requirement. The court concluded that Glenmark’s failure to provide such a writing within the initial thirty-day period effectively terminated the agreement and entered summary judgment in favor of the appellees.

The key issue in this appeal is whether the trial court erred in refusing to consider extrinsic evidence as to the meaning of Paragraph 4(b). The parol evidence rule has been stated as follows:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rullan v. Goden
134 F. Supp. 3d 926 (D. Maryland, 2015)
Frederick Management Co. v. City National Bank
723 S.E.2d 277 (West Virginia Supreme Court, 2010)
Jochum v. Waste Management of West Virginia, Inc.
680 S.E.2d 59 (West Virginia Supreme Court, 2009)
Larew v. Monongahela Power Co.
487 S.E.2d 348 (West Virginia Supreme Court, 1997)
Travelers Ins. Co. v. Austin Ins. Agency, Inc.
39 F.3d 1178 (Fourth Circuit, 1994)
Haymaker v. General Tire, Inc.
420 S.E.2d 292 (West Virginia Supreme Court, 1992)
Martin v. Martin
419 S.E.2d 440 (West Virginia Supreme Court, 1991)
Yoho v. Borg-Warner Chemicals
406 S.E.2d 696 (West Virginia Supreme Court, 1991)
Cardinal State Bank, Nat. Ass'n v. Crook
399 S.E.2d 863 (West Virginia Supreme Court, 1990)
Shafi v. St. Francis Hospital
396 S.E.2d 181 (West Virginia Supreme Court, 1990)
Tri-State Asphalt Products, Inc. v. McDonough Co.
391 S.E.2d 907 (West Virginia Supreme Court, 1990)
Ohio Valley Contractors, Inc. v. Board of Education
391 S.E.2d 891 (West Virginia Supreme Court, 1990)
Bittorf v. Bittorf
390 S.E.2d 793 (West Virginia Supreme Court, 1989)

Cite This Page — Counsel Stack

Bluebook (online)
371 S.E.2d 353, 179 W. Va. 632, 1988 W. Va. LEXIS 106, Counsel Stack Legal Research, https://law.counselstack.com/opinion/glenmark-associates-inc-v-americare-of-west-virginia-inc-wva-1988.